GLUT1 as a therapeutic target in hepatocellular carcinoma

T Amann, C Hellerbrand - Expert opinion on therapeutic targets, 2009 - Taylor & Francis
Primary hepatocellular carcinoma (HCC) is one of the most fatal cancers in humans with
rising incidence in many regions around the world. Currently, no satisfactory curative …

Microbiota and breast cancer

S Mani - Progress in Molecular Biology and Translational …, 2017 - Elsevier
Breast carcinogenesis and/or cancer growth and/or drug sensitivity has a multifactorial
etiology—perhaps the least well-characterized aspect being that of the distant …

A Paradigm of Cancer Immunotherapy Based on 2-[18F]FDG and Anti–PD-L1 mAb Combination to Enhance the Antitumor Effect

X Wen, C Shi, X Zeng, L Zhao, L Yao, Z Liu, L Feng… - Clinical Cancer …, 2022 - AACR
Purpose: Efforts have been devoted to select eligible candidates for PD-1/PD-L1 immune
checkpoint blocker (ICB) immunotherapy. Here, we have a serendipitous finding of positron …

Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic …

A Evans, V Bates, H Troy, S Hewitt, S Holbeck… - Cancer chemotherapy …, 2008 - Springer
The facilitative glucose transporter Glut-1 is overexpressed and confers poor prognosis in a
wide range of solid tumours. The peri-necrotic pattern of expression often seen in human …

Positherapy: Targeted Nuclear Therapy of Breast Cancer with 18F-2-Deoxy-2-Fluoro-d-Glucose

RM Moadel, RH Weldon, EB Katz, P Lu, J Mani… - Cancer research, 2005 - AACR
Breast cancer remains a major cause of cancer death in women in the United States. Novel
therapies are needed for patients when standard treatments are ineffective. We have …

Does Positron Attachment Take Place in Water Solution?

M Bergami, J Charry, A Reyes, K Coutinho… - The Journal of …, 2024 - ACS Publications
We performed a computational study of positron attachment to hydrated amino acids,
namely glycine, alanine, and proline in the zwitterionic form. We combined the sequential …

Molecular nuclear imaging: the radiopharmaceuticals

SK Imam - Cancer biotherapy & radiopharmaceuticals, 2005 - liebertpub.com
Application of the nuclear approach for the detection of inherited diseases is an important
goal for nuclear medicine and will likely result in an important breakthrough, which will …

Gut microbiota as a positive potential therapeutic factor in carcinogenesis: an overview of microbiota-targeted therapy

F Joukar, S Mavaddati, F Mansour-Ghanaei… - Journal of …, 2020 - Springer
Cancer therapeutic methods comprising chemotherapy, radiotherapy, and surgery are so
routine in cancer treatment. Remarkably, there are several personal features which affect the …

FDG for therapy of metabolically active tumors

S Jaini, E Dadachova - Seminars in nuclear medicine, 2012 - Elsevier
18F-2-deoxy-2-fluoro-d-glucose (18F-FDG, later referred to as 19FDG) has been extensively
used in diagnostic positron emission tomography (PET) in oncology for many years. FDG is …

2DG enhances the susceptibility of breast cancer cells to doxorubicin

IM Ahmad, EH Mustafa, NH Mustafa… - … European Journal of …, 2010 - Springer
Abstract 2DG causes cytotoxicity in cancer cells by disrupting thiol metabolism while
Doxorubicin (DOX) induces cytotoxicity in tumor cells by generating reactive oxygen species …